1. Home
  2. TECX vs IIF Comparison

TECX vs IIF Comparison

Compare TECX & IIF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tectonic Therapeutic Inc.

TECX

Tectonic Therapeutic Inc.

N/A

Current Price

$28.51

Market Cap

618.9M

Sector

N/A

ML Signal

N/A

Logo Morgan Stanley India Investment Fund Inc.

IIF

Morgan Stanley India Investment Fund Inc.

N/A

Current Price

$21.97

Market Cap

210.5M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
TECX
IIF
Founded
2019
1993
Country
United States
United States
Employees
N/A
N/A
Industry
Trusts Except Educational Religious and Charitable
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
618.9M
210.5M
IPO Year
2018
N/A

Fundamental Metrics

Financial Performance
Metric
TECX
IIF
Price
$28.51
$21.97
Analyst Decision
Strong Buy
Analyst Count
5
0
Target Price
$75.20
N/A
AVG Volume (30 Days)
197.6K
25.6K
Earning Date
05-07-2026
01-01-0001
Dividend Yield
N/A
13.94%
EPS Growth
40.70
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$14.39
$19.83
52 Week High
$39.53
$27.99

Technical Indicators

Market Signals
Indicator
TECX
IIF
Relative Strength Index (RSI) 42.68 34.27
Support Level $27.53 $22.29
Resistance Level $31.39 $22.66
Average True Range (ATR) 2.23 0.19
MACD -0.59 -0.10
Stochastic Oscillator 12.54 12.50

Price Performance

Historical Comparison
TECX
IIF

About TECX Tectonic Therapeutic Inc.

Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. The company focuses on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.

About IIF Morgan Stanley India Investment Fund Inc.

Morgan Stanley India Investment Fund, Inc. is the United States based non-diversified, closed-end management investment company. Its investment objective is to achieve long-term capital appreciation through investment in equity securities of Indian Issuers. The company's portfolio of investments consists of the investment in different sectors such as auto components, banks, capital markets, construction and engineering, pharmaceuticals and others.

Share on Social Networks: